`
Sunday, 23 July 2017

China News

  • Eisai buys Chinese Generics Company Liaoning TianYi

    China |  News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2016

    Singapore: Eisai announced that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical previously announced on November 27, 2015, the ...Read more

  • CMC, RuiYi develop monoclonal antibodies cell line

    China |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2013

    Singapore: US-based contract biopharmaceutical manufacturing CMC Biologics has collaborated with China-focused RuiYi to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibod...Read more

  • Hutchinson begins human clinical trial of cancer drug

    China |  News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2012

    Singapore: Hutchison MediPharma (HMP) has initiated the first-in-human phase I clinical trial of Theliatinib (HMPL-309). This is the fourth oncology compound from the internal discovery pr...Read more

  • Now allegations against infant formulation giant in China

    China |  News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2013

    Singapore: Accusations of bribing medical staff to boost sales of infant formulas at hospitals in Northern China were hurled against Dumex, a unit of French food group Danone's milk powder ...Read more

  • China ramps up efforts to curb Ebola

    China |  News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2014

    Singapore: The Chinese mobile laboratory stationed at the Sierra Leone-China Friendship Hospital at Jui, is playing an instrumental role in facilitating Ebola laboratory tests in the devast...Read more

  • Chinese army grants $35 mn contract to cancer care firm

    China |  News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2012

    Singapore: Elekta, which develops tools and treatment planning systems for cancer care, has won a major tender in China for the Health Department of the People's Liberation Army (PLA). The ...Read more

  • Biomics turns RNAi into therapeutics

    China |  Influencers | By Vipul Murarka | 0 Comment | 18 May, 2012

    Biomics Biotechnologies, founded in February 2006, is today Asia's leading RNA interference (RNAi) therapeutical technology company. It owns a portfolio of more than 40 patents and patent a...Read more

  • CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies

    China |  News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015

    Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-based autologous immunotherapy to treat solid tumors, has partnered wit...Read more

  • Chinese firm Tencent invests in Practo

    China |  News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2015

    Singapore: Practo has announced that it has received a $90 million investment in a Series C funding round. This round was led by Tencent, with participation from marquee institutional inves...Read more

  • China Jo-Jo Drugstores acquires Hangzhou Sanhao Grand Pharmacy

    China |  News | By BioSpectrum Bureau | 0 Comment | 16 Dec, 2014

    Singapore: China Jo-Jo Drugstores, China's healthcare retail service provider, has acquired Hangzhou Sanhao Grand Pharmacy, a Hangzhou-based pharmacy chain with 11 stores. Mr Lei Liu, chai...Read more

  • F&S: Private hospital sector to grow in APAC

    China |  Analysis | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013

    Singapore: About 180 million new hospital beds will be needed over the next decade to meet the rising healthcare demand in Asia Pacific, more than 40 percent of which is expected to come fr...Read more

  • PharmaEngine signs deal with Guangzhou BeBetter

    China |  News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013

    Singapore: Taipei-based biopharmaceutical company PharmaEngine has signed a collaboration and research agreement with Guangzhou BeBetter Medicine Technology. The two companies will collabor...Read more

  • Amgen forms JV to launch cancer drug in China

    China |  News | By BioSpectrum Bureau | 0 Comment | 21 May, 2013

    Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will own 49 percent of interest. The new firm will be ...Read more

  • Guerbet to supply liver cancer imaging technology in China

    China |  News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2015

    Singapore: Gloal medical imaging firm, Guerbet (GBT), has partnered with Beijing Kyuan Pharmaceutical, drug distributors and importers in the Chinese market, to distribute and commercialize...Read more

  • Celsion launches cancer drug trial in China

    China |  News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2016

    Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, has launched OPTIMA Study in China. The OPTIM...Read more

  • China SFDA passes Sihuan Pharma's Roxatidine

    China |  News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012

    Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the company's first-to-market generic drug, passed on-site inspection for dr...Read more

  • MicuRx to initiate Ph II trial of antibiotics

    China |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2015

    Singapore: MicuRx Pharmaceuticals, US and China based biopharmaceutical company developing next-generation antibiotics, has recieved USFDA approval to initiate Phase 2 clinical study in the...Read more

  • Medigus, Sinopharm enter endoscopic deal in China

    China |  News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2013

    Singapore: Medigus, a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, has signed a distribution agreement for SRSII System...Read more

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls